New York, NY – August 25, 2016 – Sichenzia Ross Friedman Ference LLP announced today that the Firm has represented Biomerica, Inc. (NASDAQ: BMRA), in the Company’s uplisting to the NASDAQ Capital Market. The Sichenzia Ross Friedman Ference LLP team was led by founding Partner Gregory Sichenzia and Associate Jay Yamamoto. The uplisting is effective for trading on August 26, 2016 and Biomerica’s common stock will trade under its existing stock symbol “BMRA.”
“We congratulate Biomerica on this milestone, one we believe will support the Company’s strategic capital markets objectives as it continues to develop its innovative medical diagnostic products,” said Gregory Sichenzia, founding partner of Sichenzia Ross Friedman Ference.
To learn more about SRFK, visit www.srfK.com, SRFK’s LinkedIn, Twitter: @SRFKLLP and Facebook pages
[starbox id=”1″]
